about
Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.Immune response in thyroid cancer: widening the boundaries.Current knowledge and future research directions in treatment-related second primary malignancies.Effect of organ size and position on out-of-field dose distributions during radiation therapy.Coupling of prostate and thyroid cancer diagnoses in the United StatesCancer Survivorship Care: Summarizing the 6 Tools for Success.Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and AdolescenceChemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation.Risk of Late Mortality and Second Malignant Neoplasms among 5-Year Survivors of Young Adult Cancer: A Report of the Childhood, Adolescent, and Young Adult Cancer Survivors Research Program.Unusual presentation of a rare cancer: histiocytic sarcoma in the brain 16 years after treatment for acute lymphoblastic leukemiaMass Spectrometry-Based Metabolomics Identifies Longitudinal Urinary Metabolite Profiles Predictive of Radiation-Induced Cancer.Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation.Testicular germ cell tumor: Short and long-term side effects of treatment among survivors.Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.Smartphone-Enabled Health Coaching Intervention (iMOVE) to Promote Long-Term Maintenance of Physical Activity in Breast Cancer Survivors: Protocol for a Feasibility Pilot Randomized Controlled Trial.Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.Risk and survival outcomes of radiation-induced CNS tumors.Comparison of Secondary and Primary Thyroid Cancers: Patient Characteristics and Postoperative Outcomes: A Cross-Sectional Analysis of Patients with Primary and Secondary Thyroid Cancers.Screening for thyroid cancer in survivors of childhood and young adult cancer treated with neck radiation.Incidence of primary and second cancers in renal transplant recipients: a multicenter cohort study.Impact of latency time on survival for adolescents and young adults with a second primary malignancy.Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer.Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin's lymphoma: Comparison of ILROG IS-RT and the GHSG IF-RT.Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease.A Retrospective Evaluation of the Benefit of Referring Pediatric Cancer Patients to an External Proton Therapy Center.Clinical features of the patient with multiple primary tumors: Single center experience.Surveillance imaging and radiation exposure in the detection of relapsed neuroblastoma.
P2860
Q30248284-6ACCE6AE-B567-43F1-8481-BE1B180B03DCQ33691512-6FE9DCD3-1666-4E9D-83ED-DF5A8A6DA322Q34310495-EB9561CD-43F6-493D-9767-15A7B1F896F9Q34604460-3C1B2993-9FA9-45C3-A80D-244539F9071CQ35153244-34368BBE-D8AD-40C8-9378-918E7792B6CDQ35569530-A64B638C-FB7D-4B7B-9985-CC489434D4D2Q35598437-9056DE24-4BA9-4016-90DD-AEBE0593CEBAQ35682335-96C29564-1C5E-403C-9B66-36AE290BFE4AQ36057728-95EDB7D3-CCEF-4CD4-85F6-C4CB909A8CDDQ36243692-F8E4A717-1A61-4159-97E7-B45A000D13B4Q36248367-3CADA8DA-4A61-45EA-ADD0-F3308991C49CQ36611678-C6D6B880-9AE9-41CF-A63A-EB2331C5E7C8Q36693181-FD999722-5CD2-4E32-9434-B7A290F4D9B6Q37159050-FDA44C2F-CED0-4075-8E34-77FFDAA35D80Q37204433-FDC8DC28-16D4-4357-8403-D53458D06AEDQ37340065-576D4BAF-5A31-478B-B347-249FF8D192DDQ38372159-9B51299B-4B59-450B-B28D-19C1CA64B6F3Q38654138-12130937-6128-4804-AC31-541BFBF3B972Q38840856-C2FE558D-1743-4A10-99F5-5C7380680C12Q38866545-AF2D1F74-3F56-4343-BA1E-70F0AB1BBA36Q39060125-F9439E01-721E-4E17-9A2D-AAEBD1D75CE3Q45840301-E6D9D4DA-7CC8-46D6-978C-9E9A8E5D0A7CQ46071080-6E24B076-B43C-4E66-8759-3995296DDF2BQ47109602-553E5880-EC7F-46F8-9615-426C26ED663FQ49108175-15FF92DD-E156-4856-8A99-CEC95089D32EQ50433334-08DFA4F8-5D8F-4F9F-AA5F-8F7DC99FB1D3Q51329280-9BA7E386-4919-457E-A589-46AE7EEE3A99Q52148944-27E85431-0285-480C-804F-308D1E0F58F0Q52760878-B926144C-12F9-4866-9A2B-9E54E76034E0Q52982329-690F9CB3-770C-4BA5-B415-AF53DF10B267
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Secondary malignancies across the age spectrum.
@en
Secondary malignancies across the age spectrum.
@nl
type
label
Secondary malignancies across the age spectrum.
@en
Secondary malignancies across the age spectrum.
@nl
prefLabel
Secondary malignancies across the age spectrum.
@en
Secondary malignancies across the age spectrum.
@nl
P2093
P2860
P1476
Secondary malignancies across the age spectrum.
@en
P2093
Andrea K Ng
Ethel S Gilbert
Lisa B Kenney
Lois B Travis
P2860
P356
10.1016/J.SEMRADONC.2009.09.002
P577
2010-01-01T00:00:00Z